Another intriguing survival pathway in MPNs has been described by Forte and coworkers, suggesting the contribution of Nestin+ BM-MSCs in acute myeloid leukemia (AML) development and chemoresistance in vivo (43). The gene discussed is NES; the disease is acute myeloid leukemia.